Keywords
How to Cite
Abstract
Objective: To evaluate the effect of chronic pancreatitis (CP) and exocrine insufficiency of the pancreas on the carotid intima media thickness (cIMT) in patients with type 2 diabetes mellitus (DM-2).
Materials and methods: 91 patients were examined, they were divided into groups: 1st group-patients with DM-2 (n = 31) group 2nd – DM-2 combined with CP (n = 60). Fasting plasma glucose (FPG), HbA1c, immunoreactive insulin (IRI), HOMA-IR index, C-reactive protein (CRP), serum α-amylase and fecal-1 elastase (FE-1) were assessed. In order to assess the thickness of the cIMT, ultrasound of the common carotid artery was performed. The control group of healthy volunteers was representative by age and sex.
Results: In the 1st and 2nd groups, the average value of cIMT was (1.02 ± 0.1 vs 1.21 ± 0.15) mm. Parameters of DM-2 management in the 1st and 2nd groups were (FPG 8.18 ± 0.92vs8.57 ± 1.2) mmol / l; HbA1c (7.23 ± 0.21vs7.49 ± 0.36)%; IRI (20.31 ± 0.9vs22.53 ± 1.2) μIU / ml; HOMA-IR (6.55 ± 1.5vs8.38 ± 2.2) μIU / ml * mmol / l; PSA (1.3 ± 0.12vs6.77 ± 0.31). HOMA-IR correlated with: CRP (r = 0.43, p <0.05 in group 1; r = 0.61, p <0.05 in group 2); FE-1 (r = -0.55, p <0.05 of the 2nd group); and cIMT (r = 0.42, p <0.05 in the 1st group; r = 0.53, p <0.05 in the 2nd group). IRI have relationship with: FE-1 (r = 0.41, p <0.05 in group 1; r = -0.3, p <0.05 in group 2); CRP (r = 0.42, p <0.05 in group 1; r = -0.28, p <0.05 in group 2); HbA1c had close relationships with cIMT (r = 0.38, p <0.05 in group 1; r = 0.51, p <0.05 in group 2). The relationship between cIMT and CRP was related in the 2nd group (r = 0.39, p <0.05); with α-amylase (r = 0.2, p <0.01 2nd group). There was no significant relationship between cIMT and FE-1 in the study.
Conclusions: Obtained data allows us to conclude that hyperinsulinemia and insulin resistance have a direct atherogenic effect on the walls of blood vessels. It is established that the accession of the inflammatory process leads to increasing development of atherosclerotic lesions of the vessel, at the same time, the presence of exocrine dysfunction of the pancreas does not have a significant direct effect on the cIMT.
References
Gubergric, N. B., Kazjulin, A. N. (2011). Metabolicheskaja pankreatologija. Doneck: Lebed', 514 s.
Komissarenko , I. A. (2009). Polimorbidnost' i metabolicheskij sindrom u pozhilyh. Klinicheskaja gerontologija, 1, 29–38.
Piciucchi, M., Capurso, G., et al. (2015). Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrinol, 2015:595649. doi: 10.1155/2015/595649.
Pezzilli, R., Calculli, L. (2014). Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J Diabetes, 5, 415–419.
Lew , D., Afghani , E., Pandol S. (2017, ). Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci, 62(7), 1702–1712.
Rosso, D., Carnazzo , G (2001). Atherosclerosis and pancreatic damage. Arch Gerontol Geriatr, 32(2), 95–100.
Lohr, J.M., Panic, N. (2018). The ageing pancreas: a systematic review of the evidence and analysis of the consequences. J Intern Med, 283, 446–460. DOI: 10.1111/joim.12745.
Gullo, L., Stella, A. (1982). Cardiovascular lesions in chronic pancreatitis. Digest Dis Sci, 27, 716. 9. de la Iglesia, D., Vallejo-Senra, N. et al. (2018). Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J Gastroenterol Hepatol, 34(1), 277-283. doi: 10.1111/jgh.14460. Epub 2018 Sep 25. PMID: 30156337.
Carpenter, M., Sinclair, H. (2016). Carotid intima media thickness and its utility as a predictor of cardiovascular disease: a review of evidence. Cardiol Rev, 24, 70–75.
Liviakis , L., Pogue , B., Paramsothy , P. (2010). Carotid intima-media thickness for the practicing lipidologist. J Clin Lipidol, 4, 24–35.
Polak, J. F , Pencin, M. J. (2011). Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med, 365, 213–21.
Baldassarre , D., Hamsten , A (2012). Measurements of carotid intima-media thickness and. of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (carotid intima media thickness [IMT] and IMT-progression as predictors of vascular events in a high risk european population) study. J Am Coll Cardiol, 60, 1489–1499.
O'Leary, D. H., Polak, J. F, Kronma. I. R. A., et al. (1999). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 340, 14–22.
Lorenz, M. W, Marku. s, H. S., Bots, M. L., et al. (2007). Prediction of clinical cardiovascular events with carotid intimamedia thickness: a systematic review and meta-analysis. Circulation, 115, 459–467.
Shoji, T., Kawagishi, T., Emoto M., et al. (2000). Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis, 153, 257–258.
Yoshida, M., Mita, T., Yamamoto, R., et al. (2012). Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care, 35, 178–80.
Malik, S., Budof, M. J., Katz, R., et al. (2011). Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care, 34, 2285–90.
Katakami, N., Mita, T, . Gosho, M. (2018). Clinical utility of carotid ultrasonography in the prediction of cardiovascular events in patients with diabetes: a combined analysis of data obtained in fve longitudinal studies. J Atheroscler Thromb, 25, 1053–66.
Aronson, D., Edelman, E. R. (2014). Coronary artery disease and diabetes mellitus. Cardiology Clinics, 32(3), 439–455.
Cecilia, C., Wang, L. (2016). Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations. Circulation, 133(24), 2459–2502.
Citovs'kij, M. N., Statistichnij (2017). Klinichnna ta morfologichnij aspekti vplivu cukrovogo diabetu na stan sercevo-sudinnoi sistemi. Naukovij visnik Uzhgorods'kogo universitetu. Serija:Medicina, 1, 168–177.
Paneni, F, . Lischer, T.F. (2017). Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. Am J Med, 130(6S), S18–S29.
Avogaro, A., Fadini, G.P, Sest. i, G., Bonora, E., Del Prato, S. (2016). Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice. Cardiovasc Diabetol, 15, 111.
Brohall, G., Oden, A., Fagerberg, B. (2006). Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med, 23, 609–616.
Gomez-Marcos, M.A., Recio-Rodriguez, J.I., et al. ( 2011). Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol, 10, 90.
Boncler, M., Wu, Y., Watala, C. (2019). The Multiple Faces of C-Reactive Protein — Physiological and Pathophysiological Implications in Cardiovascular Disease. Molecules, 24(11), 2062. https://doi.org/10.3390/molecules24112062
Paffen, E., deMaat, M. P. M. (2006). C-reactive protein in atherosclerosis: A causal factor? Cardiovascular Research, 71(1), 30–39. https://doi.org/10.1016/j.cardiores.2006.03.004
Steyers, C. M., Miller, F. J. (2014). Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci, 15, 11324-11349. PMID: 24968272. DOI: 10.3390/ijms150711324.
Szuszkiewicz-Garcia, M. M., Davidson, J. A. (2014). Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. Endocrinol Metab Clin North Am, 43, 25-40. PMID: 24582090. DOI: 10.1016/j.ecl.2013.09.001.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.
Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.